|Bid||65.15 x 900|
|Ask||66.33 x 900|
|Day's Range||64.41 - 67.27|
|52 Week Range||43.90 - 100.77|
|Beta (5Y Monthly)||1.42|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 19, 2024 - Feb 23, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||92.69|
Subscribe to Yahoo Finance Plus to view Fair Value for EXAS
Investors are optimistic about Exact Sciences (EXAS), driven by growth in Screening and Precision Oncology segments.
Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, its Investor Class fund ARTSX returned -7.98%, Advisor Class fund APDSX posted a return of -7.96%, and Institutional Class fund APHSX returned -7.97%, compared to a […]